Mathew Blackman
Stock Analyst at Stifel
(4.69)
# 196
Out of 4,413 analysts
25
Total ratings
68%
Success rate
24.01%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $37 → $40 | $36.20 | +10.50% | 2 | Apr 23, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $5.42 | +66.05% | 2 | Mar 13, 2024 | |
| GMED Globus Medical | Maintains: Buy | $61 → $64 | $50.43 | +26.91% | 3 | Feb 21, 2024 | |
| PODD Insulet | Maintains: Hold | $163 → $208 | $170.27 | +22.16% | 2 | Feb 5, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $25 → $24 | $12.97 | +85.04% | 3 | Nov 7, 2023 | |
| DXCM DexCom | Maintains: Buy | $155 → $145 | $125.88 | +15.19% | 4 | Oct 10, 2023 | |
| OFIX Orthofix Medical | Downgrades: Hold | $30 → $16 | $13.03 | +22.84% | 3 | Sep 12, 2023 | |
| INGN Inogen | Maintains: Hold | $15 → $8 | $7.05 | +13.48% | 4 | Aug 8, 2023 | |
| AHCO AdaptHealth | Downgrades: Hold | $18 → $11 | $10.06 | +9.34% | 2 | May 10, 2023 |
Tandem Diabetes Care
Apr 23, 2024
Maintains: Buy
Price Target: $37 → $40
Current: $36.20
Upside: +10.50%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $5.42
Upside: +66.05%
Globus Medical
Feb 21, 2024
Maintains: Buy
Price Target: $61 → $64
Current: $50.43
Upside: +26.91%
Insulet
Feb 5, 2024
Maintains: Hold
Price Target: $163 → $208
Current: $170.27
Upside: +22.16%
Alphatec Holdings
Nov 7, 2023
Maintains: Buy
Price Target: $25 → $24
Current: $12.97
Upside: +85.04%
DexCom
Oct 10, 2023
Maintains: Buy
Price Target: $155 → $145
Current: $125.88
Upside: +15.19%
Orthofix Medical
Sep 12, 2023
Downgrades: Hold
Price Target: $30 → $16
Current: $13.03
Upside: +22.84%
Inogen
Aug 8, 2023
Maintains: Hold
Price Target: $15 → $8
Current: $7.05
Upside: +13.48%
AdaptHealth
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $10.06
Upside: +9.34%